ImpriMed

ImpriMed is a company engaged in the development of precision cancer treatment for canines. It provides personalized drug testing services. The Company studies patients' drug responses and helps veterinary oncologists to prescribe a final treatment. In addition, it collects gene and cell information from pets' cancer cells and organizes them in a database.